Look at the annual reports for Nabi. They have some very interesting projects on the go and are linked to GSK re licensing and farm out deals. They are in the doldrums because of a few key failures but thats biotech land. They look interesting. WhO cares anyway. We are off to the US of A.
Pack your bags people.